We're joined by Michael Brotherton, Managing Partner at Dragonfly 44 Capital, a firm that specializes in the burgeoning fields of neuropsychiatry and psychedelic industries.  Dragonfly 44 Capital supports companies at the cutting edge of health technology, aiming to revolutionize mental health and wellness.